Presentation is loading. Please wait.

Presentation is loading. Please wait.

ITV-Based Robust Optimization for VMAT Planning of Stereotactic Body Radiation Therapy of Lung Cancer  Xiaoying Liang, PhD, Dandan Zheng, PhD, Maria Mamalui-Hunter,

Published byΛωΐς Βέργας Modified over 5 years ago

Similar presentations

Presentation on theme: "ITV-Based Robust Optimization for VMAT Planning of Stereotactic Body Radiation Therapy of Lung Cancer  Xiaoying Liang, PhD, Dandan Zheng, PhD, Maria Mamalui-Hunter,"— Presentation transcript:

1 ITV-Based Robust Optimization for VMAT Planning of Stereotactic Body Radiation Therapy of Lung Cancer  Xiaoying Liang, PhD, Dandan Zheng, PhD, Maria Mamalui-Hunter, PhD, Stella Flampouri, PhD, Bradford S. Hoppe, MD, MPH, Nancy Mendenhall, MD, Zuofeng Li, DSc  Practical Radiation Oncology  Volume 9, Issue 1, Pages (January 2019) DOI: /j.prro Copyright © 2018 American Society for Radiation Oncology Terms and Conditions

2 Figure 1 Axial view of CIRS phantom.
Practical Radiation Oncology 2019 9, 38-48DOI: ( /j.prro ) Copyright © 2018 American Society for Radiation Oncology Terms and Conditions

3 Figure 2 Example of isodose distribution and dose-volume histogram comparison of internal target volume– and planning target volume–based plans. Practical Radiation Oncology 2019 9, 38-48DOI: ( /j.prro ) Copyright © 2018 American Society for Radiation Oncology Terms and Conditions

4 Figure 3 Relative dose reductions in various normal lung tissue dose-volume parameters in internal target volume–based plans compared with corresponding planning target volume–based plans in phantom study. Practical Radiation Oncology 2019 9, 38-48DOI: ( /j.prro ) Copyright © 2018 American Society for Radiation Oncology Terms and Conditions

5 Figure 4 Relative integral dose and dose spillage reductions in internal planning target volume–based plans compared with planning target volume–based plans in phantom study. Practical Radiation Oncology 2019 9, 38-48DOI: ( /j.prro ) Copyright © 2018 American Society for Radiation Oncology Terms and Conditions

6 Figure 5 Normal lung tissue dose reduction and body dose spillage reduction in internal target volume–based plans compared with planning target volume–based plans for patient cases. Practical Radiation Oncology 2019 9, 38-48DOI: ( /j.prro ) Copyright © 2018 American Society for Radiation Oncology Terms and Conditions

Download ppt "ITV-Based Robust Optimization for VMAT Planning of Stereotactic Body Radiation Therapy of Lung Cancer  Xiaoying Liang, PhD, Dandan Zheng, PhD, Maria Mamalui-Hunter,"

Similar presentations

Neutron radiation therapy for advanced thyroid cancers Tobias R. Chapman, MD, George E. Laramore, PhD, MD, Stephen R. Bowen, PhD, Peter F. Orio, DO, MS.

Neutron radiation therapy for advanced thyroid cancers Tobias R. Chapman, MD, George E. Laramore, PhD, MD, Stephen R. Bowen, PhD, Peter F. Orio, DO, MS.
Detection of recurrent prostate cancer after primary radiation therapy: An evaluation of the role of multiparametric 3T magnetic resonance imaging with.

Detection of recurrent prostate cancer after primary radiation therapy: An evaluation of the role of multiparametric 3T magnetic resonance imaging with.
Management of independent motion between multiple targets in lung cancer radiation therapy  Feng Liu, PhD, An Tai, PhD, Ergun Ahunbay, PhD, Elizabeth.

Management of independent motion between multiple targets in lung cancer radiation therapy  Feng Liu, PhD, An Tai, PhD, Ergun Ahunbay, PhD, Elizabeth.
John Boyle, MD, Brad Ackerson, MD, Lin Gu, MS, Chris R. Kelsey, MD 

John Boyle, MD, Brad Ackerson, MD, Lin Gu, MS, Chris R. Kelsey, MD 
Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate.

Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate.
Efficacy and toxicity of rectal cancer reirradiation using IMRT for patients who have received prior pelvic radiation therapy  Fady F. Youssef, MS, Parag.

Efficacy and toxicity of rectal cancer reirradiation using IMRT for patients who have received prior pelvic radiation therapy  Fady F. Youssef, MS, Parag.
Dosimetric analysis of varying cord planning organ at risk volume in spine stereotactic body radiation therapy  Dawn Owen, MD, PhD, Charles S. Mayo, PhD,

Dosimetric analysis of varying cord planning organ at risk volume in spine stereotactic body radiation therapy  Dawn Owen, MD, PhD, Charles S. Mayo, PhD,
Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT)  Neal E. Dunlap,

Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT)  Neal E. Dunlap,
Impact of magnetic resonance imaging on computed tomography-based treatment planning and acute toxicity for prostate cancer patients treated with intensity.

Impact of magnetic resonance imaging on computed tomography-based treatment planning and acute toxicity for prostate cancer patients treated with intensity.
Hippocampal-sparing and target volume coverage in treating 3 to 10 brain metastases: A comparison of Gamma Knife, single-isocenter VMAT, CyberKnife, and.

Hippocampal-sparing and target volume coverage in treating 3 to 10 brain metastases: A comparison of Gamma Knife, single-isocenter VMAT, CyberKnife, and.
Should we irradiate a brain tumor in a patient with parkinsonism

Should we irradiate a brain tumor in a patient with parkinsonism
RTOG 0631 phase 2/3 study of image guided stereotactic radiosurgery for localized (1- 3) spine metastases: Phase 2 results  Samuel Ryu, MD, Stephanie L.

RTOG 0631 phase 2/3 study of image guided stereotactic radiosurgery for localized (1- 3) spine metastases: Phase 2 results  Samuel Ryu, MD, Stephanie L.
Evaluation of adherence to quality measures for prostate cancer radiotherapy in the United States: Results from the Quality Research in Radiation Oncology.

Evaluation of adherence to quality measures for prostate cancer radiotherapy in the United States: Results from the Quality Research in Radiation Oncology.
Clinical evaluation of interfractional variations for whole breast radiotherapy using 3- dimensional surface imaging  Amish P. Shah, PhD, Tomas Dvorak,

Clinical evaluation of interfractional variations for whole breast radiotherapy using 3- dimensional surface imaging  Amish P. Shah, PhD, Tomas Dvorak,
Jennifer C. Ho, MD, Quynh-Nhu Nguyen, MD, Heng Li, PhD, Pamela K

Jennifer C. Ho, MD, Quynh-Nhu Nguyen, MD, Heng Li, PhD, Pamela K
One in every 14 patients with early-stage lung cancer is not being treated!  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular Surgery 

One in every 14 patients with early-stage lung cancer is not being treated!  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular Surgery 
It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible  Alessandro Brunelli,

It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible  Alessandro Brunelli,
Disparities in Treatment of Patients with Inoperable Stage I Non–Small Cell Lung Cancer: A Population-Based Analysis  Matthew Koshy, MD, Renuka Malik,

Disparities in Treatment of Patients with Inoperable Stage I Non–Small Cell Lung Cancer: A Population-Based Analysis  Matthew Koshy, MD, Renuka Malik,
Michael C. Roach, MD, Gregory M. M. Videtic, MD, CM, FRCPC, Jeffrey D

Michael C. Roach, MD, Gregory M. M. Videtic, MD, CM, FRCPC, Jeffrey D
Severe Local Toxicity after Lung Stereotactic Body Radiation Therapy: Lesional Abscess Leading to Bronchocutaneous Fistula Requiring Surgical Marsupialization 

Severe Local Toxicity after Lung Stereotactic Body Radiation Therapy: Lesional Abscess Leading to Bronchocutaneous Fistula Requiring Surgical Marsupialization 

Similar presentations

Ads by Google